Occidental Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$499K Buy
8,230
+544
+7% +$31.7K 0.06% 163
2025
Q4
$415K Sell
7,686
-741
-9% -$35.6K 0.05% 174
2025
Q3
$380K Buy
8,427
+29
+0.3% +$1.35K 0.05% 182
2025
Q2
$389K Sell
8,398
-35
-0.4% -$1.72K 0.05% 170
2025
Q1
$514K Sell
8,433
-1,596
-16% -$93K 0.08% 134
2024
Q4
$567K Buy
10,029
+8
+0.1% +$447 0.09% 130
2024
Q3
$518K Buy
10,021
+886
+10% +$41.6K 0.08% 142
2024
Q2
$379K Buy
9,135
+637
+7% +$28.5K 0.07% 148
2024
Q1
$461K Sell
8,498
-1,380
-14% -$70.3K 0.09% 137
2023
Q4
$507K Sell
9,878
-193
-2% -$10.1K 0.11% 136
2023
Q3
$585K Sell
10,071
-1,500
-13% -$91.9K 0.14% 126
2023
Q2
$740K Hold
11,571
0.17% 124
2023
Q1
$802K Hold
11,571
0.2% 114
2022
Q4
$833K Buy
11,571
+1,150
+11% +$86.7K 0.23% 109
2022
Q3
$741K Hold
10,421
0.22% 106
2022
Q2
$802K Sell
10,421
-75
-0.7% -$5.71K 0.24% 105
2022
Q1
$767K Hold
10,496
0.2% 108
2021
Q4
$654K Sell
10,496
-1,100
-9% -$64.5K 0.16% 130
2021
Q3
$686K Hold
11,596
0.18% 124
2021
Q2
$775K Sell
11,596
-248
-2% -$16.2K 0.21% 115
2021
Q1
$748K Sell
11,844
-13,217
-53% -$822K 0.22% 111
2020
Q4
$1.55M Buy
25,061
+506
+2% +$31.1K 0.52% 40
2020
Q3
$1.48M Sell
24,555
-11
-0% -$662 0.62% 30
2020
Q2
$1.44M Buy
24,566
+1,864
+8% +$111K 0.64% 28
2020
Q1
$1.26M Buy
22,702
+12,633
+125% +$772K 0.64% 28
2019
Q4
$646K Buy
10,069
+150
+2% +$8.59K 0.26% 99
2019
Q3
$503K Sell
9,919
-100
-1% -$4.7K 0.21% 104
2019
Q2
$454K Hold
10,019
0.2% 104
2019
Q1
$478K Hold
10,019
0.23% 95
2018
Q4
$521K Hold
10,019
0.29% 65
2018
Q3
$622K Hold
10,019
0.31% 68
2018
Q2
$554K Sell
10,019
-2,000
-17% -$108K 0.3% 62
2018
Q1
$760K Hold
12,019
0.41% 47
2017
Q4
$737K Hold
12,019
0.38% 48
2017
Q3
$766K Hold
12,019
0.42% 45
2017
Q2
$670K Sell
12,019
-150
-1% -$8.16K 0.4% 45
2017
Q1
$662K Sell
12,169
-150
-1% -$8.23K 0.44% 40
2016
Q4
$720K Hold
12,319
0.52% 44
2016
Q3
$664K Hold
12,319
0.54% 43
2016
Q2
$906K Buy
12,319
+4,019
+48% +$284K 0.79% 37
2016
Q1
$530K Hold
8,300
0.64% 38
2015
Q4
$571K Sell
8,300
-100
-1% -$6.61K 0.73% 31
2015
Q3
$497K Hold
8,400
0.7% 33
2015
Q2
$559K Hold
8,400
0.75% 34
2015
Q1
$542K Hold
8,400
0.68% 33
2014
Q4
$496K Sell
8,400
-900
-10% -$50.8K 0.76% 36
2014
Q3
$476K Hold
9,300
0.78% 28
2014
Q2
$451K Hold
9,300
0.77% 33
2014
Q1
$483K Buy
+9,300
New +$495K 0.86% 28

Other funds holding BMY

Occidental Asset Management's BMY Position: Q1 2026 in Review

Occidental Asset Management increased its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, buying an estimated $31.7K and bringing the position to 8,230 shares worth $499K. The position accounts for 0.06% of the portfolio, ranked #163.

Occidental Asset Management first reported a position in BMY in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.55M in Q4 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Occidental Asset Management held 8,230 shares of Bristol-Myers Squibb worth $499K as of Q1 2026.
  • Occidental Asset Management bought 544 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.7K.
  • Bristol-Myers Squibb made up 0.06% of Occidental Asset Management's portfolio in Q1 2026, its #163 holding.
  • Occidental Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 49 quarters since.
  • Occidental Asset Management's Bristol-Myers Squibb position peaked at $1.55M in Q4 2020.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.